ACIU
Price
$1.63
Change
+$0.05 (+3.16%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
150.62M
Earnings call today
ARCT
Price
$12.88
Change
+$0.23 (+1.82%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
330.05M
18 days until earnings call
Ad is loading...

ACIU vs ARCT

Header iconACIU vs ARCT Comparison
Open Charts ACIU vs ARCTBanner chart's image
AC Immune SA
Price$1.63
Change+$0.05 (+3.16%)
Volume$722
Capitalization150.62M
Arcturus Therapeutics Holdings
Price$12.88
Change+$0.23 (+1.82%)
Volume$2.33K
Capitalization330.05M
ACIU vs ARCT Comparison Chart
Loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. ARCT commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and ARCT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ACIU: $1.57 vs. ARCT: $12.63)
Brand notoriety: ACIU and ARCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 108% vs. ARCT: 105%
Market capitalization -- ACIU: $150.62M vs. ARCT: $330.05M
ACIU [@Biotechnology] is valued at $150.62M. ARCT’s [@Biotechnology] market capitalization is $330.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileARCT’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • ARCT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 6 TA indicator(s) are bullish while ARCT’s TA Score has 4 bullish TA indicator(s).

  • ACIU’s TA Score: 6 bullish, 2 bearish.
  • ARCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than ARCT.

Price Growth

ACIU (@Biotechnology) experienced а +4.67% price change this week, while ARCT (@Biotechnology) price change was +22.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

ACIU is expected to report earnings on Aug 06, 2025.

ARCT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($330M) has a higher market cap than ACIU($151M). ARCT YTD gains are higher at: -25.575 vs. ACIU (-41.852). ACIU has higher annual earnings (EBITDA): -48.62M vs. ARCT (-77.4M). ARCT has more cash in the bank: 237M vs. ACIU (165M). ACIU has less debt than ARCT: ACIU (5.43M) vs ARCT (28.6M). ARCT has higher revenues than ACIU: ARCT (138M) vs ACIU (27.3M).
ACIUARCTACIU / ARCT
Capitalization151M330M46%
EBITDA-48.62M-77.4M63%
Gain YTD-41.852-25.575164%
P/E RatioN/AN/A-
Revenue27.3M138M20%
Total Cash165M237M70%
Total Debt5.43M28.6M19%
FUNDAMENTALS RATINGS
ACIU vs ARCT: Fundamental Ratings
ACIU
ARCT
OUTLOOK RATING
1..100
1116
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9492
PRICE GROWTH RATING
1..100
9385
P/E GROWTH RATING
1..100
7999
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARCT's Valuation (50) in the Pharmaceuticals Major industry is in the same range as ACIU (51). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ACIU (100). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as ACIU (94). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ARCT's Price Growth Rating (85) in the Pharmaceuticals Major industry is in the same range as ACIU (93). This means that ARCT’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as ARCT (99). This means that ACIU’s stock grew similarly to ARCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUARCT
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITYYX51.74N/A
N/A
Invesco Technology Y
HNMDX12.68N/A
N/A
Heartland Mid Cap Value Institutional
TRLWX21.25N/A
N/A
Nuveen Large Cap Value W
HSEIX10.69N/A
N/A
Hartford Small Cap Value I
VSQRX14.94N/A
N/A
Invesco MSCI World SRI Index R

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with BDTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then BDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+4.67%
BDTX - ACIU
54%
Loosely correlated
+0.96%
ARCT - ACIU
39%
Loosely correlated
+3.78%
RGNX - ACIU
35%
Loosely correlated
+13.43%
PRME - ACIU
34%
Loosely correlated
+4.14%
FHTX - ACIU
34%
Loosely correlated
+10.38%
More

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with BMEA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+3.78%
BMEA - ARCT
51%
Loosely correlated
+5.64%
ABCL - ARCT
49%
Loosely correlated
+0.79%
AXON - ARCT
49%
Loosely correlated
+3.82%
TRDA - ARCT
48%
Loosely correlated
N/A
RCKT - ARCT
45%
Loosely correlated
+2.44%
More